(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HOPO THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HOPO THERAPEUTICS

ST13

US500000088850776

Class

42

Filing

88850776

Registration

7588633

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

63

Latest update

12/03/2024

Trademark type

Word

Nice classes

42

Filing date

03/27/2020

Registration date

12/03/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/03/2024

Last transaction

12/03/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/14/2020

First use in commerce

10/08/2024

Drawing code

4

Owner type

03

Owner location

Berkeley, CA

Examiner

FERRER PEREZ, PAUL

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

HOPO Therapeutics, Inc.

Representatives

HOPO Therapeutics, Inc.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development in the pharmaceutical and biotechnology fields

Publications

History of USPTO decisions and trademark events.

63 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/03/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/12/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/12/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/18/2024

IUAF

USE AMENDMENT FILED

10/11/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/11/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/17/2024

EX5G

SOU EXTENSION 5 GRANTED

07/17/2024

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

07/12/2024

NREV

NOTICE OF REVIVAL - E-MAILED

07/12/2024

PETG

PETITION TO REVIVE-GRANTED

07/12/2024

PROA

TEAS PETITION TO REVIVE RECEIVED

07/12/2024

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

05/13/2024

ABN6

ABANDONMENT - NO USE STATEMENT FILED

05/13/2024

EXT5

SOU EXTENSION 5 FILED

04/12/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/07/2024

EX4G

SOU EXTENSION 4 GRANTED

03/06/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/04/2024

NREV

NOTICE OF REVIVAL - E-MAILED

01/14/2024

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

01/13/2024

NREV

NOTICE OF REVIVAL - E-MAILED

01/13/2024

PETG

PETITION TO REVIVE-GRANTED

01/13/2024

PROA

TEAS PETITION TO REVIVE RECEIVED

01/13/2024

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

11/13/2023

ABN6

ABANDONMENT - NO USE STATEMENT FILED

11/13/2023

EXT4

SOU EXTENSION 4 FILED

10/12/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/12/2023

EX3G

SOU EXTENSION 3 GRANTED

04/10/2023

EXT3

SOU EXTENSION 3 FILED

04/10/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/10/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/13/2022

EX2G

SOU EXTENSION 2 GRANTED

10/11/2022

EXT2

SOU EXTENSION 2 FILED

10/11/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/11/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/14/2022

EX1G

SOU EXTENSION 1 GRANTED

04/12/2022

EXT1

SOU EXTENSION 1 FILED

04/12/2022

EEXT

SOU TEAS EXTENSION RECEIVED

04/12/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/12/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/17/2021

PUBO

PUBLISHED FOR OPPOSITION

08/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/28/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/13/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

07/12/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/12/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

07/12/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/02/2021

ALIE

ASSIGNED TO LIE

05/27/2021

NREV

NOTICE OF REVIVAL - E-MAILED

03/01/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/28/2021

PETG

PETITION TO REVIVE-GRANTED

02/28/2021

PROA

TEAS PETITION TO REVIVE RECEIVED

02/28/2021

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

12/31/2020

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

12/31/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/18/2020

GNRT

NON-FINAL ACTION E-MAILED

06/18/2020

CNRT

NON-FINAL ACTION WRITTEN

06/18/2020

DOCK

ASSIGNED TO EXAMINER

06/17/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/02/2020

NWAP

NEW APPLICATION ENTERED

03/31/2020

Continuous trademark protection

Get notified about every new filing that threatens HOPO THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.